Sec. 301. Reauthorization of the critical path public-private partnership
52 words·~1 min read·
/bill/117/hr/1437/eah/section-301A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 566(f) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–5(f) ) is amended by striking $1,265,753 for the period beginning on October 1, 2022 and ending on December 16, 2022 and inserting $1,380,822 for the period beginning on October 1, 2022 and ending on December 23, 2022 .
Connections1 off-index
1 reference not yet in our index
- 21 USC 360bbb–5(f)
Citation graph
cites case law
Sec. 301
Reauthorization of the critical path public-private partnership
Cite21 USC 360bbb–5(f)
Cites 1Cited by 0 across 0 sources